secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2025-09-25T23:59:59+00:00
Accession:  0001214659-25-014200
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro issues 300,000 shares on conversion of Series B Preferred Stock
------------------------------------------------------------------------------

- Issued 300,000 common shares upon conversion of 696 Series B Preferred shares between Sep 17-25, 2025.
- Common shares outstanding as of Sep 25, 2025: 3,439,861.
- Shares issued in reliance on Section 4(a)(2) exemption; no registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465925014200/0001214659-25-014200-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465925014200/w9252538k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-25-014200

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer